Lunit

328130.KQ

43.44 USD

-5.87

-11.90%

Overview

Last close

43.44 usd

Market cap

1.25B usd

52 week high

90.42 usd

52 week low

23.45 usd

Target price

40.15 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

69.7597

Price/Book Value

7.794

Enterprise Value

1.25B usd

EV/Revenue

45.6203

EV/EBITDA

-45.3273

Key financials

Revenue TTM

18.02M usd

Gross Profit TTM

4.60M usd

EBITDA TTM

-39.89M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

453.95B usd

Net debt

N/A usd

About

Lunit Inc. develops and provides AI based software solutions for cancer screening/diagnosis and treatment. It offers AI solution for chest X-ray and mammography, as well as AI-powered biomarker for immune phenotyping and PD-L1 quantification for immunotherapy. The company was incorporated in 2013 and is based in Seoul, South Korea.